Al-Ani AJ and Jones AM. Mechanistic Investigation of a Novel Medium-sized Ring Rearrangement. Synlett, 2018, 29, 589-592 E-first.
Gill DM, Iveson M, Collins I, Jones AM. A Mitsunobu reaction to functionalized cyclic and bicyclic N-arylamines” Tetrahedron Lett. 2018, 59, 238-242.
Barone MR and Jones AM. Selective C-H Bond Electro-oxidation of Benzylic Acetates and Alcohols to Benzaldehydes. Org. Biomol. Chem. 2017, accepted DOI: 10.1039/C7OB02300F.
Green MT, Peczkowski GP, Al-Ani AJ, Benjamin SL, Simpkins NS and Jones AM* Total Synthesis and Structural Revision of a Mangrove Alkaloid. RSC Adv. 2017, 7, 48754-48758.
Bataille CJR, Brennan MB, Byrne S, Davies SG, Durbin M, Fedorov O, Huber KVM, Jones AM, Knapp S, Liu G, Nadali A, Quevedo CE, Russell AJ, Walker RG, Westwood R and Wynne GM. Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family. Bioorg. Med. Chem. 2017, 25, 2657-2665.
Mahmoud AM, Wilkinson FL, Jones AM, Wilkinson JA, Romero M, Duarte J and Alexander MY. A novel role for small molecule glycomimetics in the protection against lipid-induced endothelial dysfunction: involvement of Akt/eNOS and Nrf2/ARE signaling BBA General Subjects 2017, 1861, 3311-3322.
Jones AM, Westwood IM, Osborne JD, Matthews TP, Cheeseman MD, Rowlands MG, Jeganathan F, Burke R, Lee D, Kadi N, Liu M, Richards M, McAndrew C, Yahya N, Dobson SE, Jones K, Workman P, Collins I, van Montfort RLM. A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms. Sci. Rep. 2016, 6, 34701.
Jones AM, Patterson S, Lorion ML, Slawin AMZ, Westwood NJ. A Core Switching Strategy to Pyrrolo[2,3-b]quinolines and Diazocino[1,2-a]indolinones. Org. Biomol. Chem. 2016, 14, 8998-9011.
Cheeseman MD, Westwood IM, Barbeau O, Rowlands M, Dobson S, Jones AM, Jeganathan F, Burke R, Kadi N, Workman P, Collins I, van Montfort RLM, Jones K. Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70. J. Med. Chem. 2016, 59, 4625−4636.